number of ozempic wegovy prescriptions q3 2024 semaglutide tirzepatide The Multi-Sector Impacts GLP-1RA Drugs Semaglutide vs Tirzepatide: Which GLP-1

Most researchers who make it through the initial escalation period find long-term side effects manageable

In clinical trials, participants taking tirzepatide lost approximately 21% of their body weight on average, compared to about 3.1% in the placebo group

Both medications: Reduce appetite Help control cravings Improve blood sugar regulation Support long-term weight management Are administered as weekly injections Recent head-to-head clinical research found that tirzepatide users achieved approximately 20.2% average weight loss compared with 13.7% for semaglutide over 72 weeks

The clinical data is consistent

For many people, food was a coping mechanism, a source of comfort, a stress reliever, a social connector

Lyophilized powder versus reconstituted solution